Follow @stockstobuy
The next Intercept Pharmaceuticals (ICPT) could be Clovis Oncology (CLVS) said Citigroup analyst on CNBC Friday night. Shares of Clovis (CLVS) jumped 10% to $81.50 in after hours, down from the high of nearly $92. Citigroup has a $109 price target on CLVS for 2014. The analysts expects strong data to be released in January 2014. We will be watching it in the Stock Picks Group.
Also see - Top Stocks 2014 - Top Stock Gainers 2014
